title: Borderline Lepromatous Leprosy: Cutaneous Manifestation and Type 1 Reversal Reaction.
authors.affiliation: Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan.
authors.forename: Mai
authors.initials: M
authors.lastname: Hattori
authors.forename: Sei-Ichiro
authors.initials: S
authors.lastname: Motegi
authors.forename: Hiroo
authors.initials: H
authors.lastname: Amano
authors.forename: Norihisa
authors.initials: N
authors.lastname: Ishii
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishikawa
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D015439:Leprosy, Borderline / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D015440:Leprosy, Lepromatous / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D009167:Mycobacterium lepraemurium / Q000187:drug effects / Q000302:isolation & purification*; D011237:Predictive Value of Tests; D012867:Skin / Q000187:drug effects / Q000382:microbiology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids